Click to Share

Filter News
Show All Results
News By Country
News By Tag
Pricing And Reimbursement Remove

August 2017

Public Company News

Business Press Releases

Pricing And Reimbursement Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By SMi Group
SMi Reports: Sanofi Market Access Director to Present Case Study Insight at 23rd Annual Pharmaceutical Pricing & Market Access Industry Summit
By SMi Group
SMi Group reports (2015.07.20 – London, UK): Infusion Pharma Consulting, Rare Disease UK, Pfizer and GSK to present at the 4th annual Orphan Drugs and Rare Diseases Conference in London
By SMi Group Ltd
SMi is proud to have Dr. Günter Harms, Market Access & Public Affairs Director at Shire, giving the opening address at this year’s Orphan Drugs and Rare Diseases conference taking place in London on October 20th and 21st 2014.
By SFL Regulatory Affairs & Scientific Communication
Shayesteh Fürst-Ladani will speak at the Market Access Preliminary Skills for Regulatory Professionals event.
By Visiongain Ltd.
The global economic crisis and rising healthcare costs have caused governments to take cautious approaches towards pricing and reimbursement (P&R) for pharmaceuticals.

Page updated every 10 minutes

Like PRLog?
Click to Share